233 related articles for article (PubMed ID: 9124855)
1. Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model.
Garrison MW; Anderson DE; Campbell DM; Carroll KC; Malone CL; Anderson JD; Hollis RJ; Pfaller MA
Antimicrob Agents Chemother; 1996 Dec; 40(12):2859-64. PubMed ID: 9124855
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia.
Poulos CD; Matsumura SO; Willey BM; Low DE; McGeer A
Antimicrob Agents Chemother; 1995 Oct; 39(10):2220-3. PubMed ID: 8619571
[TBL] [Abstract][Full Text] [Related]
3. Drug Susceptibility Assessment in Stenotrophomonas Maltophilia Strains Isolated From the Blood of Organ Transplantation Recipients in a Warsaw Teaching Hospital During 2011 to 2014.
Usarek P; Dobrzaniecka K; Szymanek-Majchrzak K; Sawicka-Grzelak A; Mlynarczyk A; Durlik M; Ciszek M; Paczek L; Chmura A; Kwiatkowski A; Mlynarczyk G
Transplant Proc; 2016 Jun; 48(5):1411-3. PubMed ID: 27496417
[TBL] [Abstract][Full Text] [Related]
4. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy.
Vartivarian S; Anaissie E; Bodey G; Sprigg H; Rolston K
Antimicrob Agents Chemother; 1994 Mar; 38(3):624-7. PubMed ID: 8203865
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic susceptibility profile of Xanthomonas maltophilia. In vitro activity of beta-lactam/beta-lactamase inhibitor combinations.
García-Rodríguez JA; García Sánchez JE; García García MI; García Sánchez E; Muñoz Bellido JL
Diagn Microbiol Infect Dis; 1991; 14(3):239-43. PubMed ID: 1889176
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
Wei C; Ni W; Cai X; Zhao J; Cui J
PLoS One; 2016; 11(3):e0152132. PubMed ID: 26999818
[TBL] [Abstract][Full Text] [Related]
7. Stenotrophomonas (Xanthomonas) maltophilia: in vitro susceptibility to selected antimicrobial drugs, single and combined, with and without defibrinated human blood.
Traub WH; Leonhard B; Bauer D
Chemotherapy; 1998; 44(5):293-304. PubMed ID: 9732143
[TBL] [Abstract][Full Text] [Related]
8. Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing.
Gülmez D; Cakar A; Sener B; Karakaya J; Hasçelik G
J Infect Chemother; 2010 Oct; 16(5):322-8. PubMed ID: 20449623
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinations.
Krueger TS; Clark EA; Nix DE
Diagn Microbiol Infect Dis; 2001; 41(1-2):71-8. PubMed ID: 11687317
[TBL] [Abstract][Full Text] [Related]
10. The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management.
Smit WJ; Boquest AL; Geddes JE; Tosolini FA
Pathology; 1994 Jul; 26(3):321-4. PubMed ID: 7991292
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of antibiotic susceptibility of Stenotrophomonas maltophilia using a polyclonal antibody developed against an ABC multidrug efflux pump.
Al-Hamad A; Burnie J; Upton M
Can J Microbiol; 2011 Oct; 57(10):820-8. PubMed ID: 21942332
[TBL] [Abstract][Full Text] [Related]
12. Stenotrophomonas (Xanthomonas) maltophilia: a multidrug-resistant nosocomial pathogen.
Penzak SR; Abate BJ
Pharmacotherapy; 1997; 17(2):293-301. PubMed ID: 9085321
[TBL] [Abstract][Full Text] [Related]
13. Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia.
Tripodi MF; Andreana A; Sarnataro G; Ragone E; Adinolfi LE; Utili R
Eur J Clin Microbiol Infect Dis; 2001 Jan; 20(1):73-5. PubMed ID: 11245333
[No Abstract] [Full Text] [Related]
14. Evaluation of antibacterial activity of five biocides and the synergistic effect of biocide/EDTA combinations on biofilm-producing and non-producing Stenotrophomonas maltophilia strains isolated from clinical specimens in Iran.
Anari RK; Nikkhahi F; Javadi A; Bakht M; Rostamani M; Kelishomi FZ; Alizadeh SA
BMC Microbiol; 2022 Oct; 22(1):257. PubMed ID: 36271327
[TBL] [Abstract][Full Text] [Related]
15. [Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
Monteil H; Jehl F
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):805-8. PubMed ID: 3309818
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Stenotrophomonas maltophilia isolates from cystic fibrosis patients in Russia.
Bocharova YA; Savinova TA; Lyamin AV; Kondratenko OV; Polikarpova SV; Zhilina SV; Fedorova NI; Semykin SY; Chaplin AV; Korostin DO; Mayansky NA; Chebotar IV
Klin Lab Diagn; 2022 May; 67(5):315-320. PubMed ID: 35613352
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
Cantón R; Valdezate S; Vindel A; Sánchez Del Saz B; Maíz L; Baquero F
Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
[TBL] [Abstract][Full Text] [Related]
18. [Kinetics of bactericidal activity of cefepime and cefpirome alone or combined with gentamicin, amikacin or ciprofloxacin against Acinetobacter baumannii, Stenotrophomonas maltophilia and Enterobacter cloacae hyperproductive in cephalosporinase].
Elkhaïli H; Pompei D; Linger L; Kamili N; Monteil H; Jehl F
Pathol Biol (Paris); 1996 May; 44(5):367-73. PubMed ID: 8758478
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of beta-lactam-beta-lactamase inhibitor combinations against Stenotrophomonas maltophilia: correlation between methods for testing inhibitory activity, time-kill curves, and bactericidal activity.
Muñoz Bellido JL; Muñoz Criado S; García García I; Alonso Manzanares MA; Gutiérrez Zufiaurre MN; García-Rodríguez JA
Antimicrob Agents Chemother; 1997 Dec; 41(12):2612-5. PubMed ID: 9420028
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility and synergy studies of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis.
San Gabriel P; Zhou J; Tabibi S; Chen Y; Trauzzi M; Saiman L
Antimicrob Agents Chemother; 2004 Jan; 48(1):168-71. PubMed ID: 14693535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
